Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,255 | -4,370 | -2,276 | -1,368 | -8,621 |
| Depreciation Amortization | 12 | 10 | 7 | 3 | 22 |
| Other Working Capital | -130 | -404 | -354 | -296 | -969 |
| Other Operating Activity | 514 | 983 | -32 | 199 | 3,266 |
| Operating Cash Flow | $-4,859 | $-3,782 | $-2,655 | $-1,462 | $-6,302 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -272 | 79 | 79 | N/A | N/A |
| Other Investing Activity | 34 | 34 | 0 | 0 | -26 |
| Investing Cash Flow | $-238 | $112 | $79 | $N/A | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,297 | 5,964 | 5,481 | 5,323 | 11,705 |
| Other Financing Activity | -43 | -33 | -19 | -6 | -41 |
| Financing Cash Flow | $6,254 | $5,931 | $5,462 | $5,317 | $11,664 |
| Exchange Rate Effect | -12 | -10 | -7 | 4 | -38 |
| Beginning Cash Position | 5,428 | 5,428 | 5,428 | 5,428 | 129 |
| End Cash Position | 6,574 | 7,680 | 8,306 | 9,286 | 5,428 |
| Net Cash Flow | $1,146 | $2,252 | $2,878 | $3,858 | $5,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,859 | -3,782 | -2,655 | -1,462 | -6,302 |
| Free Cash Flow | -4,859 | -3,782 | -2,655 | -1,462 | -6,302 |